Propanc Biopharma’s Management Explains Why They Believe Cancer Patients Are Likely to Respond to PRP Treatment
Clinical Knowledge Obtained Increases Probability of Success Compared to Drug Products Entering Phase I without…
Clinical Knowledge Obtained Increases Probability of Success Compared to Drug Products Entering Phase I without…
QpiAI signed a Memorandum of Understanding (MoU) with Anglo-Finnish quantum control software company QuantrolOx QpiAI…
Today at the New York Auto Show, Subaru of America has announced that the 2023…
$6.1 Million investment for Pictor — led by Marko Bogoievski and K One W One…
ZURICH & LONDON & NOIDA, India--(BUSINESS WIRE)--#AI--HCL Technologies (HCL), a leading global technology company, has…
Agreement shows strength of GPM’s successful growth strategy RICHMOND, Va., April 13, 2022 (GLOBE NEWSWIRE)…
DALLAS and WALL, N.J., April 13, 2022 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI),…
CAMBRIDGE, Mass. & BRISBANE, Australia--(BUSINESS WIRE)--Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform,…
AUCKLAND, New Zealand & IRVINE, Calif.--(BUSINESS WIRE)--#EmpowerYourPurpose--MitoQ Ltd., a New Zealand-based cell health company that…
Global crisis response non-profit launches prepaid cards program in collaboration with EML, the Stichting Giustra…